Analyst predicts that covid-19 will still affect Demant
On Tuesday morning, Demant will present its interim management statement for Q1, in which it is expected that corona will play a significant role. The firm will also report on the reception of Oticon More.
BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN
Covid-19, increasing infection rates and restrictions in many markets will keep being significant in Danish hearing aid firm Demant's communication when the firm presents its interim management statement for Q1 early on Tuesday.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
FDA postpones plan for new hearing aid sales channel – again
For subscribers
